Mullany LK - Search Results

1

A steroid receptor coactivator stimulator (MCB-613) attenuates adverse remodeling after myocardial infarction.

Mullany LK, Rohira AD, Leach JP, Kim JH, Monroe TO, Ortiz AR, Stork B, Gaber MW, Sarkar P, Sikora AG, Rosengart TK, York B, Song Y, Dacso CC, Lonard DM, Martin JF, O'Malley BW. Mullany LK, et al. Proc Natl Acad Sci U S A. 2020 Dec 8;117(49):31353-31364. doi: 10.1073/pnas.2011614117. Epub 2020 Nov 23. Proc Natl Acad Sci U S A. 2020. PMID: 33229578 Free PMC article.

2

Wound Healing-related Functions of the p160 Steroid Receptor Coactivator Family.

Mullany LK, Lonard DM, O'Malley BW. Mullany LK, et al. Endocrinology. 2021 Mar 1;162(3):bqaa232. doi: 10.1210/endocr/bqaa232. Endocrinology. 2021. PMID: 33340403 Free PMC article. Review.

3

[No title available]

[No authors listed] [No authors listed] PMID: 33508118

4

[No title available]

[No authors listed] [No authors listed] PMID: 33570121

5

Wild-type tumor repressor protein 53 (Trp53) promotes ovarian cancer cell survival.

Mullany LK, Liu Z, King ER, Wong KK, Richards JS. Mullany LK, et al. Endocrinology. 2012 Apr;153(4):1638-48. doi: 10.1210/en.2011-2131. Epub 2012 Mar 6. Endocrinology. 2012. PMID: 22396451 Free PMC article.

6

Mutant p53 Promotes Epithelial Ovarian Cancer by Regulating Tumor Differentiation, Metastasis, and Responsiveness to Steroid Hormones.

Ren YA, Mullany LK, Liu Z, Herron AJ, Wong KK, Richards JS. Ren YA, et al. Among authors: mullany lk. Cancer Res. 2016 Apr 15;76(8):2206-18. doi: 10.1158/0008-5472.CAN-15-1046. Epub 2016 Mar 10. Cancer Res. 2016. PMID: 26964623 Free PMC article.

7

Consequences of RAS and MAPK activation in the ovary: the good, the bad and the ugly.

Fan HY, Liu Z, Mullany LK, Richards JS. Fan HY, et al. Among authors: mullany lk. Mol Cell Endocrinol. 2012 Jun 5;356(1-2):74-9. doi: 10.1016/j.mce.2011.12.005. Epub 2011 Dec 16. Mol Cell Endocrinol. 2012. PMID: 22197887 Free PMC article. Review.

8

Minireview: animal models and mechanisms of ovarian cancer development.

Mullany LK, Richards JS. Mullany LK, et al. Endocrinology. 2012 Apr;153(4):1585-92. doi: 10.1210/en.2011-2121. Epub 2012 Mar 6. Endocrinology. 2012. PMID: 22396450 Free PMC article. Review.

9

Tumor repressor protein 53 and steroid hormones provide a new paradigm for ovarian cancer metastases.

Mullany LK, Liu Z, Wong KK, Deneke V, Ren YA, Herron A, Richards JS. Mullany LK, et al. Mol Endocrinol. 2014 Jan;28(1):127-37. doi: 10.1210/me.2013-1308. Epub 2013 Jan 1. Mol Endocrinol. 2014. PMID: 24264574 Free PMC article.

10

Nutlin-3a: A Potential Therapeutic Opportunity for TP53 Wild-Type Ovarian Carcinomas.

Crane EK, Kwan SY, Izaguirre DI, Tsang YT, Mullany LK, Zu Z, Richards JS, Gershenson DM, Wong KK. Crane EK, et al. Among authors: mullany lk. PLoS One. 2015 Aug 6;10(8):e0135101. doi: 10.1371/journal.pone.0135101. eCollection 2015. PLoS One. 2015. PMID: 26248031 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters